Henry Schein Inc (NAS:HSIC)
$ 73.31 -0.13 (-0.18%) Market Cap: 9.39 Bil Enterprise Value: 11.95 Bil PE Ratio: 24.68 PB Ratio: 2.62 GF Score: 88/100

Henry Schein Inc at Piper Sandler Healthcare Conference (Virtual) Transcript

Dec 01, 2020 / 06:00PM GMT
Release Date Price: $64.91 (+0.93%)
Sarah James

Hello, and thank you for joining us for Piper's 32nd Annual Healthcare Conference this year coming to you virtually. I'm Sarah James, healthcare services analyst at Piper. And with us today here, we're very pleased to have Henry Schein, a global distributor of medical and dental supplies, including vaccines, pharmaceuticals, financial services and equipment. With us, we have Stan Bergman, Henry Schein's CEO; and Steve Paladino, Henry Schein's CFO.

Steve, I'm going to pass it off to you to make some opening comments.

Steven Paladino
Henry Schein, Inc. - Executive VP, CFO & Executive Director

Okay. Thank you, Sarah. As we begin, I'd like to note that certain comments made during this call may include information that is forward-looking. As you know, risks and uncertainties involved in the company's business may affect the matters referred to in forward-looking statements. As a result, the company's performance may differ from those expressed in or indicated by such forward-looking statements. And these forward-looking statements are qualified

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot